Summary
Medline: After IPO In 2025, This Year Is A Bet On Continued Growth
Medline Inc. is rated a buy, driven by robust sector macroeconomics, strong ROE, organic Q1 growth, and a favorable Fitch investment-grade rating. MDLN's top-line growth is compelling, with net sales up 10.7% YoY, fueled by new customer signings and international market penetration. Despite positive revenue trends, MDLN faces margin pressure from rising costs, volatile cash flows, and a rich 37x forward earnings multiple, warranting caution.
Medline (MDLN) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Medline (MDLN) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Medline Inc. (MDLN) Q1 2026 Earnings Call Transcript
Medline Inc. (MDLN) Q1 2026 Earnings Call Transcript
Medline Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| CE Curtis Ellergodt Rothschild Investment LLC | 55 | $2,310 | $2,179.92 | -$130.08 | -5.63% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 1,479 | $62,120.5 | $58,139.49 | -$3,981.01 | -6.41% |
 George Soros Soros Fund Management LLC | 1.29M | $54.03M | $50.94M | -$3.09M | -5.72% |
 Lone Pine Capital Lone Pine Capital | 11.79M | $495.33M | $466.8M | -$28.52M | -5.76% |
| AC Adam Claypool First Community Trust Na | 200 | $8,400 | $7,907.4 | -$492.6 | -5.86% |
Medline Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Glen Santangelo Barclays | 178.1 | $7,563.6 | $7,319.18 | -$244.42 | -3.23% |
Medline Inc. (MDLN) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Medline Inc. ever had a stock split?
Medline Inc. Profile
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | James Boyle CEO | NASDAQ (NMS) Exchange | 58507V107 CUSIP |
| US Country | 45,000 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Medline Inc. is a leading manufacturer of medical-surgical products that cater to a wide array of healthcare settings, including hospitals, surgery centers, physician offices, post-acute facilities, and nursing homes across the United States and internationally. Founded in 1966 and headquartered in Northfield, Illinois, Medline operates through two primary segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment focuses on the procurement and manufacturing of products across three key categories: surgical solutions, front line care, and laboratory and diagnostics. Meanwhile, the Supply Chain Solutions segment is dedicated to procuring and distributing a range of third-party products from national brands while offering comprehensive logistics and supply chain optimization services to both domestic and international clients.
Products and Services
- Front Line Care:
This category encompasses a variety of med-surg products designed for patient-facing needs. The offerings include wound care products essential for managing and treating patient injuries, exam gloves crucial for infection prevention, skin care and incontinence products to maintain patient hygiene, environmental cleaning supplies to ensure sanitized care settings, textiles including sheets and gowns, hand sanitizer for maintaining hand hygiene, durable medical equipment for patient care, patient plastics, and products aimed at decolonization and infection control.
- Surgical Solutions:
The surgical solutions segment provides products designed for the operating room and perioperative environment. Among the offerings are surgical procedure trays containing all necessary instruments, drapes and gowns to maintain a sterile environment, personal protective equipment essential for the safety of healthcare providers, sterile wraps for surgical instruments, a variety of surgical instruments, surgeon's gloves, procedure kits tailored for specific surgeries, and orthopedic implants used in various surgical procedures.
- Laboratory and Diagnostics:
This segment includes a range of laboratory and diagnostic product solutions. Key products comprise point of care testing devices for quick patient assessment, analyzers and instrumentation for laboratory analyses, lab and diagnostic consumables necessary for daily operations, diagnostic instruments for various testing purposes, vital signs monitors for continuous patient monitoring, and anatomic pathology and phlebotomy products essential in lab diagnostics.
- Supply Chain Solutions:
Medline's Supply Chain Solutions segment aids healthcare providers by procuring and distributing third-party products from established national brands. The services offered include logistics support and supply chain optimization, which help enhance efficiency in inventory management. This includes consulting engagements to tailor solutions for specific needs, outsourced warehouse and technology management, put-away-ready packaging to simplify logistics processes, third-party logistics to streamline distribution, inventory rationalization to ensure optimal stock levels, and route planning to enhance delivery efficiency.
